T. purpurea leaf extract has been utilized to synthesize facile and non-toxic silver nanoparticles. Analytical techniques were used to characterize the TP-AgNPs, including FE-SEM, EDX, UV–visible spectroscopy, FTIR spectroscopy, XRD, and zeta potential. Further, the biological activities of TP-AgNPs were examined, which advanced their applications for futuristic research purposes.
Tephrosia purpurea silver nanoparticles (TP-AgNPs) were synthesized with water-based leaf extract of the plant T. purpurea. UV–Vis characterization had shown the maximum absorbance at 436 nm. The surface morphology was examined via electron microscopy (FE-SEM) analysis (average size: ~100 nm, shape: spherical). The zeta potential (ZP) of TP-AgNPs revealed values of −41.72 mV suggesting appropriate physical stability. Besides, an X-ray crystallography (XRD) study had shown the crystalline size of 20 nm approximately having 2θ values of 32°, 38°, 44°, 64°, and 77° for the silver crystals. The energy dispersive (EDAX) study manifests the absorption peak at 2.983 keV for TP-AgNPs. Infrared spectroscopy analysis (Fourier-transform infrared spectroscopy) indicated the presence of alcoholic as well as aromatic groups in the extract that took part in the stability and silver reduction mechanisms. Biologically, TP-AgNPs had shown prominent anti-oxidant activities against 2,2-diphenyl-1-picrylhydrazyl radicals (IC50 50 μg/mL) and H2O2 radicals (IC50 106 μg/mL). It had also inhibited the proliferation of breast cell lines (MCF 7) showing total growth inhibition (TGI) at 8.2 μg/mL with the LC50 of 44 μg/mL for TP-AgNPs. Further, hemolysis analysis revealed that TP-AgNPs are non-toxic to human erythrocyte cells (RBCs) as they do not cause the breakdown of RBCs. Thus, TP-AgNPs were found to be an effective agent to be studied further for chemotherapeutic mechanisms.